National Audit of Cardiac Rhythm Management Devices April 2015 – March 2016

Reports | Published: 14 Feb 2017

This audit is commissioned and managed by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patients Outcomes Programme (NCAPOP) and covers the period 1 April 2015 to 31 March 2016. The audit is held by the National Institute for Cardiac Outcomes Research and led clinically by the British Heart Rhythm Society.

Key findings from the report are as follows:

  • Although pacemaker and defibrillator implant rates in the UK are gradually increasing, they remain consistently low in Western Europe.
  • There is great variation within the UK in the rates of all types of implants.
  • The UK is one of the top countries in Europe performing cardiac resynchronization therapy – a technique that improves the coordination of the heart in patients with heart failure.
  • A significant number of UK hospitals continue to perform small numbers of pacemaker and defibrillator implants. For pacemakers, the number of such hospitals has halved in the last year, but for more complex devices, almost 50% of hospitals do not meet recommended minima.
  • The full report is available to download from this page

View press release here

Don’t miss out. Sign up to be notified when this resource is updated and to receive updates about other related quality improvement resources, events and news from HQIP. Or you can  .

By continuing you agree to receive emails with updates and other information from HQIP and you are confirming you are over the age of 13.

Please read our privacy policy to understand how HQIP uses the information you provide, your use of HQIP’s website and your interaction with the marketing emails to improve the relevance of the communications we send you. You can unsubscribe at any time.

I have read and agree with the contents of the privacy policy.

National Audit of Cardiac Rhythm Management Devices April 2015 – March 2016